The Supply Chain and the Pandemic?

Here’s How Biden’s Infrastructure Bill Addresses Science

President Joe Biden signed a massive bipartisan infrastructure bill into law this Monday. The measure focuses on a range of sectors. It would funnel billions into cleaning up pollution in the air and water with efforts that include eliminating lead service lines and cleaning up old, polluted manufacturing sites. The bill will also invest $7.5 billion to create a large-scale network of electric vehicle chargers across the country.

In other big news this week, a new study confirms that masks are highly effective in combating COVID-19, reducing incidence of the disease by as much as 53% on its own. Researchers say this finding is significant and add that when masks are used in addition to other protective measures, like vaccines and hand washing, people can feel confident in their safety.

Joining guest host Roxanne Khamsi to talk through these and other big science stories of the week is Nsikan Akpan, health and science editor for WNYC Public Radio in New York City.

The holiday season has snuck up once again, leaving many people to figure out familiar logistics: If travel will be involved, who to see, and what will be for dinner. But of course, we’re still in a pandemic, so questions of safety remain. At the end of the day, we want to keep our families, friends, and loved ones healthy.

COVID-19 tests are becoming a popular tool, helping many people make social situations safer. Quickly swabbing your nose or spitting in a tube can indicate if someone has been infected with the coronavirus. But with so many options available, and a big season of holiday get-togethers up ahead, many are wondering what kind of test is best—and when is the best time to get tested?

Joining guest host Roxanne Khamsi to talk through COVID-19 testing questions are Dr. Céline Gounder, epidemiologist and professor at New York University’s Grossman School of Medicine in New York, and Dr. Alex Greninger, assistant director at the clinical virology laboratories at the University of Washington Medical Center in Seattle.

Despite tremendous scientific advances, there’s still so much scientists don’t understand about cancer. One of the biggest remaining questions is how do tumors form in the first place?

Researchers are getting closer to an answer. For years, the prevailing theory of tumor growth was that cancer cells gradually acquire a series of mutations that enable them to outcompete healthy cells and run amok.

But improved genetic sequencing of cancers is revealing a more complicated picture. New technology has enabled a new theory of tumor development, called the big bang theory. It turns out that some types of cancer contain a whole hodge-podge of mutations right from the very beginning, even before the tumors are detectable on a scan. Researchers initially observed this pattern in colon cancer, and then replicated the findings in pancreatic, liver, and stomach cancers, too.

Guest host Roxanne Khamsi talks to Christina Curtis, associate professor of medicine and genetics at Stanford University’s School of Medicine about her research into tumor development, and how to improve cancer diagnosis and treatment.

Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.